No one has described the fiscal disparity that arises as a result of Canada/United States (US) cross border organ transactions. Canadian healthcare cannot continue to subsidize US transplant programs while paying their inflated organ acquisition fees. Canadian hospitals should bill US transplant programs for all costs associated with procuring organs.
Be the first to comment on this!
This article is for subscribers only. To view the entire article
Note: Please enter a display name. Your email address will not be publically displayed